GSK1247446A Low Dose Influenza Vaccine Candidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1247446A Low Dose Influenza Vaccine Candidate, covering 2013-04-22 to 2013-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate [Phase 2]